Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Diathesis

medroxyprogesterone acetate has been researched along with Diathesis in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.35)18.2507
2000's3 (13.04)29.6817
2010's14 (60.87)24.3611
2020's5 (21.74)2.80

Authors

AuthorsStudies
Ayele, H; Baeten, JM; Bosinger, SE; Brown, BP; Bunjun, R; Burgener, A; Dabee, S; Gamieldien, H; Harryparsad, R; Heffron, R; Heller, KB; Jaspan, H; Jaumdally, SZ; Nair, G; Noël-Romas, L; Onono, M; Palanee-Phillips, T; Passmore, JS; Ramla, TF; Scoville, CW1
Aceves, KM; Cherpes, TL; Gabriel, JM; Hatfield, AM; Kaur, B; Kwiek, JJ; Quispe Calla, NE; Torres, AR; Trout, W; Vicetti Miguel, RD1
Ahmed, K; Baeten, JM; Batting, J; Beksinska, M; Deese, J; Donnell, D; Edward, VA; Lind, M; Louw, CE; Mastro, TD; Morrison, C; Mugo, NR; Nanda, K; Onono, M; Palanee-Phillips, T; Philip, N; Rees, H; Smit, JA1
Bagri, P; Dupont, H; Kaushic, C; Lam, J; Nazli, A; Verschoor, CP; Woods, MW; Zahoor, MA1
Ashkar, AA; Bagri, P; Deshiere, A; Dupont, HA; Felker, AM; Kaushic, C; Mazzulli, T; Mueller, K; Nguyen, PV; Tremblay, MJ; Vahedi, F; Verschoor, CP; Vitali, D; Wessels, JM1
Dizzell, S; Kaushic, C; Verschoor, CP; Woods, MW; Zahoor, MA1
Hapgood, JP; Hel, Z; Kaushic, C1
Davids, M; Dheda, K; Hapgood, JP; Meldau, R; Pooran, A; Semple, L; Smith, L; Theron, G; Tomasicchio, M1
Achilles, SL; Dorflinger, LJ; Hapgood, JP; Heffron, R; Kiarie, J; Polis, CB; Steyn, PS1
Boily-Larouche, G; Broliden, K; Cheruiyot, J; Edfeldt, G; Fowke, KR; Kimani, J; Kimani, M; Lajoie, J; Omollo, K; Oyugi, J; Röhl, M; Tjernlund, A1
Asin, S; Brache, V; Chandra, N; Chen, BA; Doncel, GF; Fichorova, RN; Herold, BC; Hillier, SL; Mauck, C; Rollenhagen, C; Schwartz, JL; Thurman, A; Weiner, DH1
Barkley, MS; Kullolli, O; Logiodice, F; Lombardelli, L; Maggi, E; Piccinni, MP1
Aceves, KM; Cherpes, TL; Quispe Calla, NE; Torres, A; Vicetti Miguel, RD1
Ferreira, VH; Kafka, JK; Kaushic, C1
Abou, M; Ball, TB; Fowke, KR; McCorrister, SJ; McKinnon, LR; Plummer, FA; Shaw, SY; Stein, DR; Westmacott, GR1
Chappell, CA; Dezzutti, CS; Hillier, SL; Isaacs, CE; Meyn, LA; Moncla, BJ; Uranker, K; Xu, W1
Butler, K; Ellis, S; Garber, D; Henning, TR; Kersh, EN; McNicholl, JM; Montague, J; Ritter, J; Zaki, S1
Boyaka, PN; Cherpes, TL; Hall-Stoodley, L; Kaur, B; Pavelko, SD; Quispe Calla, NE; Trout, W; Vicetti Miguel, RD1
Averbach, S; Critchfield, JW; Giudice, LC; Greenblatt, RM; Hilton, JF; Seidman, D; Shacklett, BL; Shanmugasundaram, U; Smith-McCune, KK1
Ashkar, AA; Kaushic, C; Reid, LA; Rosenthal, KL1
Cohen, CR; Criniti, A; Meier, AS; Mwachari, CW; Nduba, V; Ngumo, JK; Sanguli, L1
Blanchard, J; Cheng-Mayer, C; Gettie, A; Harouse, J; Schneider, E; Simon, V; Trunova, N; Tsai, L; Tung, S1
Cicinelli, E; De Mitrio, V; Galantino, P; Giannoccaro, F; Marino, R1

Reviews

2 review(s) available for medroxyprogesterone acetate and Diathesis

ArticleYear
Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.
    Endocrine reviews, 2018, 02-01, Volume: 39, Issue:1

    Topics: Animals; Contraception; Contraceptive Agents, Female; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Progestins

2018
Influence of common mucosal co-factors on HIV infection in the female genital tract.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2014, Volume: 71, Issue:6

    Topics: Contraceptives, Oral, Hormonal; Disease Susceptibility; Female; Genital Diseases, Female; Genitalia, Female; Gonadal Steroid Hormones; HIV Infections; Humans; Interferons; Medroxyprogesterone Acetate; Mucous Membrane; Semen; Tight Junctions

2014

Trials

3 trial(s) available for medroxyprogesterone acetate and Diathesis

ArticleYear
Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 11-30, Volume: 75, Issue:11

    Topics: Contraceptive Agents, Female; Copper; Disease Susceptibility; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Proteomics; South Africa; Vagina

2022
Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant.
    Sexually transmitted infections, 2021, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Africa; Chlamydia Infections; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Disease Susceptibility; Drug Implants; Female; Gonorrhea; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Prevalence; Young Adult

2021
The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition.
    AIDS research and human retroviruses, 2019, Volume: 35, Issue:9

    Topics: Adolescent; Adult; Cervix Uteri; Contraceptives, Oral; Cytokines; Disease Susceptibility; Female; HIV Infections; HIV-1; Hormonal Contraception; Humans; Injections; Medroxyprogesterone Acetate; Middle Aged; Mucous Membrane; Prospective Studies; Vagina; Young Adult

2019

Other Studies

18 other study(ies) available for medroxyprogesterone acetate and Diathesis

ArticleYear
Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
    ImmunoHorizons, 2020, 02-11, Volume: 4, Issue:2

    Topics: Animals; Contraceptive Agents, Female; Desmoglein 1; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, SCID; Mucous Membrane; Norethindrone; Permeability; Vagina

2020
Transcriptional response of vaginal epithelial cells to medroxyprogesterone acetate treatment results in decreased barrier integrity.
    Journal of reproductive immunology, 2021, Volume: 143

    Topics: Cell Line; Cell Membrane Permeability; Contraceptive Agents, Female; Disease Susceptibility; Epithelial Cells; Estradiol; Female; Gene Expression Profiling; HIV Infections; HIV-1; Humans; Medroxyprogesterone Acetate; Progesterone; Transcription, Genetic; Transcriptome; Vagina

2021
Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice.
    Scientific reports, 2021, 02-16, Volume: 11, Issue:1

    Topics: Animals; Contraceptive Agents, Hormonal; Cytokines; Delayed-Action Preparations; Disease Susceptibility; Female; HIV-1; Host-Pathogen Interactions; Humans; Infant, Newborn; Macrophages; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Vagina

2021
Medroxyprogesterone acetate-treated human, primary endometrial epithelial cells reveal unique gene expression signature linked to innate immunity and HIV-1 susceptibility.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2018, Volume: 79, Issue:1

    Topics: Adult; Cells, Cultured; Cholesterol; Contraceptive Agents, Female; Disease Susceptibility; Epithelial Cells; Female; Genitalia, Female; HIV Infections; HIV-1; Humans; Immunity, Innate; Inflammation; Medroxyprogesterone Acetate; Middle Aged; Mucous Membrane; Primary Cell Culture; Progesterone; Progestins; Tissue Array Analysis; Transcriptome

2018
The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis-Specific Host Immunity Through the Glucocorticoid Receptor.
    The Journal of infectious diseases, 2019, 04-08, Volume: 219, Issue:8

    Topics: Contraceptive Agents, Female; Dexamethasone; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Immunity; Immunity, Cellular; Medroxyprogesterone Acetate; Mycobacterium tuberculosis; Norethindrone Acetate; Receptors, Glucocorticoid; T-Lymphocytes, Regulatory; Tuberculosis, Pulmonary

2019
Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.
    Contraception, 2019, Volume: 99, Issue:4

    Topics: Contraceptive Agents, Hormonal; Disease Susceptibility; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone

2019
Increased Cervical CD4
    AIDS research and human retroviruses, 2019, Volume: 35, Issue:3

    Topics: Adult; CD4-Positive T-Lymphocytes; Cervix Uteri; Cohort Studies; Contraceptive Agents, Female; Cross-Sectional Studies; Cytokines; Disease Susceptibility; Female; HIV Infections; Humans; Kenya; Lymphocyte Activation; Medroxyprogesterone Acetate; Receptors, CCR5; Sex Workers

2019
Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease.
    Frontiers in immunology, 2019, Volume: 10

    Topics: Adult; Bacterial Infections; Basic Helix-Loop-Helix Transcription Factors; Cytokines; Disease Susceptibility; Female; Humans; Inflammation; Macrophages; Male; Medroxyprogesterone Acetate; Nuclear Receptor Subfamily 1, Group F, Member 3; Receptors, Aryl Hydrocarbon; Sex Factors; Signal Transduction; T-Box Domain Proteins; Th1 Cells; Th17 Cells; Virus Diseases

2019
Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion.
    Contraception, 2019, Volume: 100, Issue:5

    Topics: Animals; Cell Adhesion Molecules; Contraceptive Agents, Female; Desmocollins; Desmoglein 1; Disease Susceptibility; Female; Gene Expression; Herpes Genitalis; Herpesvirus 2, Human; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mucous Membrane; Vagina

2019
Mx2 expression is associated with reduced susceptibility to HIV infection in highly exposed HIV seronegative Kenyan sex workers.
    AIDS (London, England), 2015, Jan-02, Volume: 29, Issue:1

    Topics: Adult; Disease Susceptibility; Female; HIV Infections; HIV Seronegativity; HIV-1; Humans; Immunity, Innate; Kenya; Leukocytes, Mononuclear; Medroxyprogesterone Acetate; Myxovirus Resistance Proteins; Proteomics; Sex Workers

2015
The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
    American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:2

    Topics: Adult; Cervix Uteri; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Immunity, Innate; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Postmenopause; Premenopause; Vagina; Vaginal Douching; Viral Plaque Assay; Young Adult

2015
Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques.
    Journal of medical primatology, 2015, Volume: 44, Issue:5

    Topics: Animals; Contraceptive Agents, Female; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Humans; Hydrogen-Ion Concentration; Macaca nemestrina; Medroxyprogesterone Acetate; Menstrual Cycle; Mucous Membrane; Progesterone; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Vagina

2015
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.
    Mucosal immunology, 2016, Volume: 9, Issue:6

    Topics: Animals; Contraceptive Agents, Female; Disease Models, Animal; Disease Susceptibility; Estrogens; Female; Herpes Genitalis; Herpesvirus 2, Human; Levonorgestrel; Medroxyprogesterone Acetate; Mice; Mucous Membrane; Permeability; Vagina

2016
Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility.
    Mucosal immunology, 2017, Volume: 10, Issue:5

    Topics: Adult; CD4-Positive T-Lymphocytes; Cellular Microenvironment; Cervix Uteri; Chemokine CCL2; Contraceptive Agents; Delayed-Action Preparations; Disease Susceptibility; Endometrium; Female; HIV Infections; Humans; Interferon-alpha; Interleukin-1beta; Interleukin-6; Medroxyprogesterone Acetate; Receptors, CCR5; Young Adult

2017
Progesterone increases susceptibility and decreases immune responses to genital herpes infection.
    Journal of virology, 2003, Volume: 77, Issue:8

    Topics: Animals; Antibodies, Viral; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Immunity; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Progesterone; Reproduction; Vaccines, Attenuated; Vagina; Vaginal Diseases; Viral Envelope Proteins

2003
Association of hormonal contraception and HIV-seroprevalence in Nairobi, Kenya.
    AIDS (London, England), 2003, Dec-05, Volume: 17, Issue:18

    Topics: Adolescent; Adult; Age Distribution; CD4 Lymphocyte Count; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease Susceptibility; Female; HIV Seropositivity; Humans; Kenya; Medroxyprogesterone Acetate; Parity; Progesterone; Seroepidemiologic Studies

2003
Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques.
    Virology, 2006, Aug-15, Volume: 352, Issue:1

    Topics: Animals; Contraceptive Agents, Female; Disease Susceptibility; Female; HIV Infections; HIV-1; Humans; Interferon-gamma; Lymphocyte Activation; Macaca mulatta; Medroxyprogesterone Acetate; Progestins; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; T-Lymphocytes; Viral Load; Virus Replication

2006
Improved sensitivity to activated protein C following postmenopausal hormone replacement therapy.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1998, Volume: 9, Issue:3

    Topics: Administration, Cutaneous; Adult; Aged; Blood Coagulation; Disease Susceptibility; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Factor V; Factor VIII; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Postmenopause; Protein C; Protein S; Thrombophilia

1998